首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤多药耐药与自噬的研究进展
引用本文:赵英迪,刘克辛. 肿瘤多药耐药与自噬的研究进展[J]. 现代药物与临床, 2018, 41(1): 5-13
作者姓名:赵英迪  刘克辛
作者单位:大连医科大学药学院, 辽宁 大连 116044,大连医科大学药学院, 辽宁 大连 116044
基金项目:国家自然科学基金项目(81473280)
摘    要:肿瘤多药耐药(multidrug resistance,MDR)对肿瘤的药物治疗的疗效有严重的影响。多药耐药拥有十分复杂的发生发展的机制。通过讨论自噬与药物抗肿瘤时的相互影响,旨在阐明自噬与肿瘤细胞多药耐药的关系,为今后抗肿瘤药物治疗的临床应用提供新的思路。

关 键 词:肿瘤  自噬  多药耐药
收稿时间:2017-06-05

Advances in multidrug resistance and autophagy of antitumor drugs
ZHAO Yingdi and LIU Kexin. Advances in multidrug resistance and autophagy of antitumor drugs[J]. Drugs & Clinic, 2018, 41(1): 5-13
Authors:ZHAO Yingdi and LIU Kexin
Affiliation:College of Pharmacy, Dalian Medical University, Dalian, Liaoning 116044, China and College of Pharmacy, Dalian Medical University, Dalian, Liaoning 116044, China
Abstract:Tumor multidrug resistance (MDR) has seriously affected the efficacy of drug therapy on tumors. The occurrence of multidrug resistance has a very complex mechanism. In this paper, we discuss the relationship between autophagy and drug anti-tumor, aiming to elucidate the relationship between autophagy and multidrug resistance in tumor cells, and provide new ideas for the clinical application of anticancer drugs.
Keywords:tumor  autophagy multidrug  resistance
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号